- Report
- September 2026
- 192 Pages
Global
From €3227EUR$3,545USD£2,777GBP
€3586EUR$3,939USD£3,086GBP
- Report
- September 2026
- 194 Pages
Global
From €3227EUR$3,545USD£2,777GBP
€3586EUR$3,939USD£3,086GBP
- Report
- March 2026
- 133 Pages
Global
From €3500EUR$4,119USD£3,118GBP
The Hemocompatible Coating market is a subset of the Medical Device Coatings market, which is used to improve the biocompatibility of medical devices. Hemocompatible coatings are designed to reduce the risk of thrombosis, inflammation, and other adverse reactions when a device is implanted in the body. These coatings are typically made of polymers, such as polyurethane, polyethylene, and polytetrafluoroethylene, and are applied to the surface of the device to reduce the risk of blood clotting. The coatings also help to reduce the risk of infection and improve the device's durability.
Some of the companies in the Hemocompatible Coating market include Surmodics, Inc., Biocoat, Inc., and Specialty Coating Systems, Inc. Show Less Read more